Regular coffee drinkers generally have a reduced risk of chronic liver disease. The type of coffee actually doesn't matter, as both caffeinated and decaffeinated coffee seem to have the same benefits. Oliver Kennedy of the University of Southampton in the UK and colleagues analyz

Regular coffee drinkers generally have a reduced risk of chronic liver disease. In fact, the type of coffee does not matter, because caffeine-containing and decaffeinated coffee seem to have the same effect.

Oliver Kennedy of the University of Southampton in the UK and colleagues analyzed data from 384,818 coffee drinkers and 109,767 non-coffee drinkers. These people were monitored for a median of 10.7 years, with liver disease ranging from chronic liver disease, chronic liver disease or steatosis (fatty liver disease), and deaths due to chronic liver disease at 3,600, 5,439, and 301 deaths respectively.

"Overall, coffee seems to be good for most healthy people. This applies not only to chronic liver disease, but also to other diseases, such as chronic kidney disease and some cancers ." Kennedy said.

"No one knows exactly which compounds are potentially protective against chronic liver disease. However, our study found that all types of coffee were protective, suggesting that a combination of compounds may be at play," Kennedy said.

These coffee drinkers drank an average of two cups of decaf, instant or ground coffee per day. They were 21% less likely to develop chronic liver disease and 20% less likely to develop chronic liver disease or steatosis than their non-coffee drinking peers. They were 49% less likely to die from chronic liver disease.

"I think it's necessary to determine how many cups of coffee you need to drink per day," says Ludovico Abenavoli of the University of Catanzaro Magna Esia in Italy. Clinical trials can provide such answers, he said, rather than looking at real-life populations. (Zhao Xixi)

Source: "Chinese Science News"

#pharmaceutical health super group##婷 Zero plan#

pharmaceutical network @pharmaceutical health—China's leading Internet pharmacist group, with members covering 31 countries across the country Province (autonomous region, municipality directly under the Central Government), has a real-name hospital pharmacist + doctor community of 6,000 people. A member of the Beijing Science and Technology Journalists and Editors Association, settled in the Wuxi Health Internet of Things Innovation Center, Tencent News’ Outstanding Industry Observer in 2019, and Toutiao’s Most Influential Organization in 2020.